Transcatheter Tricuspid Valve Replacement Following Tricuspid Edge‐To‐Edge‐Repair

Wiley
Copyright John Wiley and Sons Inc./Ltd powered by GNM Healthcare Consulting Group, LLC
Transcatheter Tricuspid Valve Replacement Following Tricuspid Edge‐To‐Edge‐Repair

Abstract
Significant tricuspid regurgitation (TR) is seen as a relevant contributor of cardiac morbidity and mortality. Transcatheter tricuspid valve replacement (TTVR) is a novel technique to treat this condition. We present the case of an 82‐year‐old lady who was admitted for recurrent right heart decompensation despite having undergone treatment with tricuspid edge‐to‐edge repair (TEER). The patient underwent transfemoral implantation of a 48 mm EVOQUE valve. Since the implanted Clip was not in the central part of the valve, it was pushed toward the valvular anulus by the expanded prothesis. Echocardiography showed a good result with no residual TR. Options for residual TR after T‐TEER are very limited. TTVR might be suitable in selected patients with non‐central Clip placement.
Keywords: EVOQUE; transcatheter tricuspid valve replacement; Triclip.